UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 COMMISSION FILE NUMBER 001-37969 ENDRA LIFE SCIENCES INC. (Exact name of registrant as specified in its charter) Delaware 26-0579295 (State of incorporation) (I.R.S. Employer Identification ...

ENDRA Life Sciences, Inc. (NASDAQ:NDRA) Q4 2021 Earnings Conference Call March 30, 2022 4:30 PM ET Company Participants Yvonne Briggs - IR Francois Michelon - Chairman and CEO Renaud Maloberti - CCO Irina Pestrikova - Senior Director, Finance Conference Call Participants Ed Woo - Ascendiant Capital Operator Good day and welcome to the ENDRA Life Sciences' Fourth Quarter 2021 Financial Results Conference Call. All participants will be in a listen-only mode. [Operator Instructions] Please note this event is b ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended: December 31, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________________ to __________________ Commission file number: 001-37969 ENDRA Life Sciences Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 2 ...

ENDRA Life Sciences, Inc. (NASDAQ:NDRA) Q3 2021 Earnings Conference Call November 15, 2021 4:30 PM ET Company Participants Yvonne Briggs ??? Investor Relations Francois Michelon ??? Chairman and Chief Executive Officer Renaud Maloberti ??? Chief Commercial Officer Irina Pestrikova ??? Senior Director of Finance Conference Call Participants Ed Woo ??? Ascendiant Capital Operator Good day, and welcome to the ENDRA Life Sciences??? Third Quarter 2021 Financial Results Conference Call. Today, all participants w ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 COMMISSION FILE NUMBER 001-37969 ENDRA LIFE SCIENCES INC. (Exact name of registrant as specified in its charter) Delaware 26-0579295 (State of incorporation) (I.R.S. Employer Identifica ...

ENDRA Life Sciences, Inc. (NASDAQ:NDRA) Q2 2021 Earnings Conference Call August 12, 2021 4:30 PM ET Company Participants Yvonne Briggs ??? Investor Relations Francois Michelon ??? Chairman and Chief Executive Officer Renaud Maloberti ??? Chief Commercial Officer Irina Pestrikova ??? Senior Director of Finance Conference Call Participants Ed Woo ??? Ascendiant Capital Markets Operator Good day, ladies and gentlemen and welcome to the ENDRA Life Sciences Second Quarter 2021 Financial Results Conference Call. ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 COMMISSION FILE NUMBER 001-37969 ENDRA LIFE SCIENCES INC. (Exact name of registrant as specified in its charter) Delaware 26-0579295 (State of incorporation) (I.R.S. Employer Identification ...

ENDRA Life Sciences Inc. (NASDAQ:NDRA) Q1 2021 Earnings Conference Call May 17, 2021 4:30 PM ET Company Participants Yvonne Briggs - Investor Relations Francois Michelon - Chairman and Chief Executive Officer Renaud Maloberti - Chief Commercial Officer David Wells - Chief Financial Officer Operator Good afternoon, ladies and gentlemen and welcome to the ENDRA Life Sciences First Quarter 2021 Financial Results Conference Call. At this time, all participants have been placed on a listen-only mode and we will ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2021 OR COMMISSION FILE NUMBER 001-37969 ENDRA LIFE SCIENCES INC. (Exact name of registrant as specified in its charter) Delaware 26-0579295 (State of incorporation) (I.R.S. Employer Identification No.) 3600 Green Court, Suite 350, Ann Arbor, MI 48105-1570 (Address of principal executive ...

ENDRA Life Sciences Inc. (NASDAQ:NDRA) Q4 2020 Earnings Conference Call March 25, 2021 4:30 PM ET Company Participants Yvonne Briggs - LHA Investor Relations Francois Michelon - Chairman and Chief Executive Officer Renaud Maloberti - Chief Commercial Officer David Wells - Chief Financial Officer Conference Call Participants Edward Woo - Ascendiant Capital Markets, LLC Operator Good afternoon, ladies and gentlemen, and welcome to the ENDRA Life Sciences Inc. Fourth Quarter 2020 Financial Results Conference C ...